Practical guide to the management of osteoporosis in men with prostate cancer receiving androgen-deprivation therapy.
Bruder
Jan M
JM
Department of Medicine, Division of Endocrinology, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA. bruder@uthscsa.edu
D015502:Absorptiometry, Photon; D000284:Administration, Oral; D000726:Androgen Antagonists / Q000009:adverse effects*; D015519:Bone Density / Q000187:drug effects; D002136:Calcium, Dietary / Q000008:administration & dosage; D004164:Diphosphonates / Q000627:therapeutic use; D016903:Drug Monitoring / Q000379:methods; D005598:Fractures, Spontaneous / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis / Q000517:prevention & control*; D011471:Prostatic Neoplasms / Q000150:complications* / Q000188:drug therapy*; D014572:Urology / Q000379:methods
D000726:Androgen Antagonists; D002136:Calcium, Dietary; D004164:Diphosphonates